General Description
Gepirone hydrochloride is an azapirone derivative structurally related to buspirone, acting as a selective serotonin 5-HT1A receptor partial agonist. Its chemical structure contains a pyrimidinylpiperazine and a bicyclic imide moiety. Unlike buspirone, gepirone has no significant affinity for dopamine D2 receptors. The hydrochloride salt enhances solubility. Gepirone is a selective serotonin modulator with minimal benzodiazepine-like or sedative properties.
Mechanism of Action
Gepirone acts as a partial agonist at presynaptic and postsynaptic 5-HT1A receptors. At presynaptic (somatodendritic) autoreceptors in the raphe nuclei, it reduces serotonergic firing (acute effect). After chronic administration, these autoreceptors desensitize, leading to increased postsynaptic 5-HT1A activation and enhanced serotonergic transmission in forebrain regions. This delayed onset of increased serotonin activity is thought to produce antidepressant effects without the sexual side effects of SSRIs.
Application
Gepirone is indicated for the treatment of major depressive disorder (MDD) in adults. It has been investigated for generalized anxiety disorder (GAD) as well. Unlike SSRIs, gepirone does not commonly cause sexual dysfunction, weight gain, or sleep disturbances. The drug is metabolized primarily by CYP3A4, and its absorption is markedly increased by food, requiring consistent administration with meals.